MediChem Research Receives $35 Million for New Lab, Other Corporate Purposes
Chemistry outsourcing company MediChem Research Inc. (Lemont, IL) has received $35 million in financing from a group led by Chase Capital Partners (New York) and MedEquity Investors LLC (Wellesley Hills, MA). As part of the transaction, MedEquity also arranged for debt financing by NationsCredit Commercial Corp., through its Healthcare Capital Division based in Atlanta.
MediChem will use the proceeds to build a new, state-of-the-art laboratory facility and headquarters in Woodridge, IL; for strategic acquisition of companies that will supplement and enhance the company's skills and market position; and for general corporate purposes.
MediChem Research Inc. is a privately held chemistry outsourcing company that offers a broad range of research and development services to pharmaceutical, biotechnology, agricultural chemical, and personal care companies involved in new product discovery and development. Founded in 1987, the company offers services traditionally provided by in-house research and development divisions, specializing in synthetic organic chemistry and its application to drug discovery and development.
Chase Capital Partners is a global investment partnership with approximately $7 billion under management.
MedEquity Investors LLC is a recently formed private equity firm sponsored by Chase Capital Partners, GE Capital Healthcare Finance Group, and other institutions.
For more information, call MediChem Research Inc. at 630-257-1500 or 888-650-CHEM.